Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis

OBJECTIVES: This post-hoc analysis explored the impact of body mass index (BMI) on tofacitinib efficacy/safety in patients with active psoriatic arthritis (PsA). METHODS: Data were pooled from two phase 3 studies (NCT01877668; NCT01882439). Analyses included patients randomised to tofacitinib 5/10 m...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:RMD Open
Main Authors: Giles, Jon T, Ogdie, Alexis, Gomez-Reino, Juan J, Helliwell, Philip S, Germino, Rebecca, Stockert, Lori, Young, Pamela, Joseph, Wael, Mundayat, Rajiv, Graham, Daniela, Ritchlin, Christopher
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2021
Fag:
Psoriatic Arthritis
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813423/
https://ncbi.nlm.nih.gov/pubmed/33452181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001486
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker